10x Genomics, Inc. TXG Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s operating lease liabilities (total)?
- 10x Genomics, Inc. (TXG) reported operating lease liabilities (total) of $81.39M in Q1 2026.
- How has 10x Genomics, Inc.'s operating lease liabilities (total) changed year-over-year?
- 10x Genomics, Inc.'s operating lease liabilities (total) increased by 1.6% year-over-year, from $80.07M to $81.39M.
- What is the long-term trend for 10x Genomics, Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s operating lease liabilities (total) has grown at a 6.0% compound annual growth rate (CAGR), from $62.98M to $84.36M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.